Kyoko Kogawa

799 total citations
10 papers, 691 citations indexed

About

Kyoko Kogawa is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kyoko Kogawa has authored 10 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kyoko Kogawa's work include TGF-β signaling in diseases (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Kyoko Kogawa is often cited by papers focused on TGF-β signaling in diseases (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). Kyoko Kogawa collaborates with scholars based in Japan. Kyoko Kogawa's co-authors include Hiromu Sugino, Koiti Titani, Yoshiki Nishizawà, Takanori Nakamura, Takahiko Kawagishi, Masayuki Hosoi, Koji Takio, Kiyoshi Maekawa, Hirotoshi Morii and Shinya Fukumoto and has published in prestigious journals such as Circulation, Circulation Research and Diabetes Care.

In The Last Decade

Kyoko Kogawa

10 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyoko Kogawa Japan 10 290 255 209 118 76 10 691
K. KIETZMANN Germany 4 312 1.1× 115 0.5× 716 3.4× 41 0.3× 34 0.4× 5 843
Timothy Tolley United States 10 318 1.1× 277 1.1× 35 0.2× 113 1.0× 28 0.4× 10 824
Zhaohui Wang China 15 153 0.5× 118 0.5× 50 0.2× 52 0.4× 23 0.3× 53 599
Shunji Hashizume Japan 5 85 0.3× 106 0.4× 82 0.4× 55 0.5× 22 0.3× 9 461
Sharon Li Ting Pek Singapore 14 394 1.4× 196 0.8× 125 0.6× 43 0.4× 12 0.2× 32 857
Asad Junaid Canada 10 219 0.8× 183 0.7× 33 0.2× 75 0.6× 13 0.2× 14 559
Meg Keil United States 16 163 0.6× 135 0.5× 670 3.2× 80 0.7× 22 0.3× 39 1.1k
Intissar Ezzidi Tunisia 14 178 0.6× 107 0.4× 147 0.7× 14 0.1× 29 0.4× 24 620
Magnus Ulvsbäck Sweden 7 144 0.5× 45 0.2× 52 0.2× 131 1.1× 25 0.3× 7 664
Parvin Amiri Iran 16 190 0.7× 66 0.3× 123 0.6× 20 0.2× 24 0.3× 33 526

Countries citing papers authored by Kyoko Kogawa

Since Specialization
Citations

This map shows the geographic impact of Kyoko Kogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Kogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Kogawa more than expected).

Fields of papers citing papers by Kyoko Kogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Kogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Kogawa. The network helps show where Kyoko Kogawa may publish in the future.

Co-authorship network of co-authors of Kyoko Kogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Kogawa. A scholar is included among the top collaborators of Kyoko Kogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Kogawa. Kyoko Kogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Taniwaki, H., Takahiko Kawagishi, M. Emoto, et al.. (1999). Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.. Diabetes Care. 22(11). 1858–1864. 44 indexed citations
2.
Emoto, Masanori, Yoshiki Nishizawà, Kiyoshi Maekawa, et al.. (1997). Insulin resistance in non-obese, non—insulin-dependent diabetic patients with diabetic nephropathy. Metabolism. 46(9). 1013–1018. 20 indexed citations
3.
Kogawa, Kyoko, Yoshiki Nishizawà, Masayuki Hosoi, et al.. (1997). Effect of Polymorphism of Apolipoprotein E and Angiotensin-Converting Enzyme Genes on Arterial Wall Thickness. Diabetes. 46(4). 682–687. 81 indexed citations
4.
Ishimura, Eiji, Yoshiki Nishizawà, Takahiko Kawagishi, et al.. (1997). Intrarenal hemodynamic abnormalities in diabetic nephropathy measured by duplex Doppler sonography. Kidney International. 51(6). 1920–1927. 114 indexed citations
5.
Koyama, Hidenori, Yoshiki Nishizawà, Masayuki Hosoi, et al.. (1996). The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth Factor-I. Circulation Research. 79(4). 757–764. 42 indexed citations
6.
Hosoi, Masayuki, Yoshiki Nishizawà, Kyoko Kogawa, et al.. (1996). Angiotensin-Converting Enzyme Gene Polymorphism Is Associated With Carotid Arterial Wall Thickness in Non–Insulin-Dependent Diabetic Patients. Circulation. 94(4). 704–707. 91 indexed citations
7.
Hasegawa, Yoshihisa, et al.. (1992). Follistatin inhibits activin-induced differentiation of rat follicular granulosa cells in vitro. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1135(1). 103–109. 35 indexed citations
8.
Saito, Sachiko, Keitaro Yamanouchi, Kyoko Kogawa, et al.. (1991). Characterization of Antisera Directed against Follistatin/Activin-Binding Protein Peptides.. Endocrinologia Japonica. 38(4). 377–382. 17 indexed citations
9.
Kogawa, Kyoko, et al.. (1991). Activin-Binding Protein Is Present in Pituitary*. Endocrinology. 128(3). 1434–1440. 194 indexed citations
10.
Kogawa, Kyoko, Kenji Ogawa, Yoshihiro Hayashi, et al.. (1991). Immunohistochemical Localization of Follistatin in Rat Tissues.. Endocrinologia Japonica. 38(4). 383–391. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026